UBS lifts target to USD 110.00 for MetLife stock

Published on 10/16/2026 at 16:23 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

MetLife posted USD 19.15 billion revenue in the second quarter of 2026. MetLife stock costs EUR 90.26 on October 16, 2026 at 4:09 p.m. CEST.

Analyst target and reporting date

On October 6, UBS lifted its MetLife target to USD 110.00 from USD 105.00.
Second-quarter revenue reached USD 19.15 billion and net income was USD 705.0 million.
MetLife stock costs EUR 90.26 at Lang & Schwarz on October 16, 2026 at 4:09 p.m. CEST.
Third-quarter results are scheduled for November 4, 2026.

Geometrisches Bauhaus-Poster in Primärfarben mit dem Schriftzug INSURANCE — Bauhaus-Poster mit geometrischen Formen und dem Sektor-Text INSURANCE, symbolisch für MetLife Inc., ISIN US59156R1086, Illustration mit AI erstellt.

UBS raised its MetLife target from USD 105.00 to USD 110.00 on October 6, implying 8.17 percent upside from the USD 101.69 home-market price. MarketBeat reported that UBS kept a Buy rating while lifting the target. MetLife stock was trading at EUR 90.26 at Lang & Schwarz on October 16, 2026 at 4:09 p.m. CEST.

Second-quarter figures set the baseline

MetLife generated USD 19.15 billion in revenue in the second quarter of 2026. Net income attributable to common shareholders was USD 705.0 million, while diluted earnings per share came to USD 1.09. Operating profit reached USD 1.04 billion in the same period.

The balance sheet carried USD 759.4 billion in total assets on June 30, 2026. Operating cash flow was USD 2.23 billion in the second quarter, giving investors a second measure of the insurer's financial scale alongside revenue and earnings.

Price position and valuation

The primary-market quote was USD 101.69 on the NYSE at 4:22 p.m. ET on October 16, 2026. MetLife's 52-week range was USD 67.33 to USD 101.86, placing the latest home-market price USD 0.17 below the high. The share price was up 1.42 percent in that session.

MetLife had a market capitalization of USD 64.6 billion and a price-to-earnings ratio of 19.51 on October 16, 2026. The trailing dividend yield was 2.00 percent. The UBS target of USD 110.00 sits 8.17 percent above the USD 101.69 home-market price.

November date and peer comparison

MetLife will release third-quarter 2026 results after the market closes on November 4, 2026, with its earnings call scheduled for November 5, 2026. The date gives the target and recent second-quarter figures a defined next checkpoint.

Comparison with peers

MetLife Inc. (NYSE, USD): P/E 19.51, market capitalization USD 64.6 billion.

Prudential Financial (NYSE, USD): daily change 0.21 percent, P/E 10.48, market capitalization USD 40.2 billion.

Aflac Incorporated (NYSE, USD): daily change 0.49 percent, P/E 12.77, market capitalization USD 59.5 billion.

Stock price in euros

MetLife stock was trading at EUR 90.26 at Lang & Schwarz on October 16, 2026 at 4:09 p.m. CEST. The latest price keeps the euro quote below the USD 110.00 UBS target when compared in their respective currencies. The further course of trading is shown by the continuously updated real-time quote of MetLife stock.